menu
    • menu

    Company profile for PharmaCyte Biotech

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    PharmaCyte Biotech is a clinical stage biotechnology company focused on developing and preparing to commercialize treatments for cancer and diabetes based upon a proprietary cellulose-based live cell encapsulation technology known as “Cell-in-a-Box®.” This unique and patented technology will be used as a platform upon which treatments for several types of cancer and diabetes are being developed. PharmaCyte’s treatmen...
    PharmaCyte Biotech is a clinical stage biotechnology company focused on developing and preparing to commercialize treatments for cancer and diabetes based upon a proprietary cellulose-based live cell encapsulation technology known as “Cell-in-a-Box®.” This unique and patented technology will be used as a platform upon which treatments for several types of cancer and diabetes are being developed. PharmaCyte’s treatment for cancer involves encapsulating genetically modified live cells that convert an inactive chemotherapy drug into its active or “cancer-killing” form.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    PharmaCyte BiotechUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    23046 Avenida de la Carlota, Suite 600 Laguna Hills, California 92653
    Telephone
    Telephone
    917.595.2850
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://pharmacyte.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/pharmacyte-biotech/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Pharmacyte Bio Monetizes Femasys Stake, Boosts Cash And Strategy
    Pharmacyte Bio Monetizes Femasys Stake, Boosts Cash And Strategy

    25 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251125795950/en/PharmaCyte-Biotech-Successfully-Monetizes-Femasys-Stake-Strengthening-Cash-Position-and-Underscoring-Strategic-Capital-Deployment

    BUSINESSWIRE
    25 Nov 2025
    Share Share
    PharmaCyte Biotech Closes $7 Million Financing Deal
    PharmaCyte Biotech Closes $7 Million Financing Deal

    20 Aug 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250820055624/en/PharmaCyte-Biotech-Inc.-Announces-Closing-of-%247-Million-Financing

    BUSINESSWIRE
    20 Aug 2025
    Share Share
    PharmaCyte Biotech Secures $7M Capital Raise From Investors
    PharmaCyte Biotech Secures $7M Capital Raise From Investors

    18 Aug 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250818528622/en/PharmaCyte-Biotech-Inc.-Announces-%247-Million-Capital-Raise-Led-by-Existing-Investors

    BUSINESSWIRE
    18 Aug 2025
    Share Share
    PharmaCyte Invests $7M In Inflammatory Disease Firm MyMD
    PharmaCyte Invests $7M In Inflammatory Disease Firm MyMD

    21 May 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240521971719/en

    BUSINESSWIRE
    21 May 2024
    Share Share
    Femasys Secures Additional Financing with Strategic Investment from Investors
    Femasys Secures Additional Financing with Strategic Investment from Investors

    15 Nov 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/11/15/2780928/0/en/Femasys-Inc-Secures-Additional-Financing-with-Strategic-Investment-from-Investors-led-by-PharmaCyte-Biotech.html

    GLOBENEWSWIRE
    15 Nov 2023
    Share Share
    PharmaCyte Biotech Provides Corporate Update on Cell-in-a-Box Technology
    PharmaCyte Biotech Provides Corporate Update on Cell-in-a-Box Technology

    31 Oct 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20231031782802/en

    BUSINESSWIRE
    31 Oct 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search